Journal article · 2019 · Open access

Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway

Maiko Omi, Vesa Kaartinen, Yuji M. Mishina

Journal of Biological Chemistry, 294(47), 17818–17836 · Published 17 October 2019 · DOI 10.1074/jbc.ra119.009521

Open PDFView at the publisherCite this paper

In brief

“Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway” is a 2019 journal article by Maiko Omi and 2 co-authors, published in Journal of Biological Chemistry. OpenAlex counts 46 citations as of 19 November 2026, which puts it in the top 4% of works published in 2019 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Biological Chemistry.

Citations
46
Most cited in
2024 (11)
Field-weighted impact
1.18
References
61
Authors
3

Abstract

Bone morphogenetic proteins (BMPs) are important mediators of osteoclast differentiation. Although accumulating evidence has implicated BMPs in osteoblastogenesis, the mechanisms by which BMPs regulate osteoclastogenesis remain unclear. Activin A receptor type 1 (ACVR1) is a BMP type 1 receptor essential for skeletal development. Here, we observed that BMP-7, which preferentially binds to ACVR1, promotes osteoclast differentiation, suggesting ACVR1 is involved in osteoclastogenesis. To investigate this further, we isolated osteoclasts from either Acvr1 -floxed mice or mice with constitutively-activated Acvr1 ( caAcvr1 ) carrying tamoxifen-inducible Cre driven by a ubiquitin promotor and induced Cre activity in culture. Osteoclasts from the Acvr1 -floxed mice had reduced osteoclast numbers and demineralization activity, whereas those from the caAcvr1 -mutant mice formed large osteoclasts and demineralized pits, suggesting that BMP signaling through ACVR1 regulates osteoclast fusion and activity. It is reported that BMP-2 binds to BMPR1A, another BMP type 1 receptor, whereas BMP-7 binds to ACVR1 to activate SMAD1/5/9 signaling. Here, Bmpr1a -disrupted osteoclasts displayed reduced phospho-SMAD1/5/9 (pSMAD1/5/9) levels when induced by BMP-2, whereas no impacts on pSMAD1/5/9 were observed when induced by BMP-7. In contract, Acvr1 -disrupted osteoclasts displayed reduced pSMAD1/5/9 levels when induced either by BMP-2 or BMP-7, suggesting that ACVR1 is the major receptor for transducing BMP-7 signals in osteoclasts. Indeed, LDN-193189 and LDN-212854, which specifically block SMAD1/5/9 phosphorylation, inhibited osteoclastogenesis of caAcvr1 -mutant cells. Moreover, increased BMP signaling promoted nuclear translocation of nuclear factor–activated T-cells 1 (NFATc1), which was inhibited by LDN treatments. Taken together, ACVR1-mediated BMP–SMAD signaling activates NFATc1, a regulatory protein crucial for receptor activator of NF-κB ligand (RANKL)–induced osteoclastogenesis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Omi, M., Kaartinen, V., & Mishina, Y. M. (2019). Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway. Journal of Biological Chemistry, 294(47), 17818–17836. https://doi.org/10.1074/jbc.ra119.009521

MLA 9

Omi, Maiko, et al. “Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.” Journal of Biological Chemistry, vol. 294, no. 47, 2019, pp. 17818–17836. https://doi.org/10.1074/jbc.ra119.009521.

Chicago

Omi, Maiko, Vesa Kaartinen, and Yuji M. Mishina. 2019. “Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.” Journal of Biological Chemistry 294 (47): 17818–17836. https://doi.org/10.1074/jbc.ra119.009521.

Harvard

Omi, M., Kaartinen, V. and Mishina, Y. M. (2019) ‘Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway’, Journal of Biological Chemistry, 294(47), pp. 17818–17836. doi:10.1074/jbc.ra119.009521.

IEEE

M. Omi, V. Kaartinen, and Y. M. Mishina, “Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway,” Journal of Biological Chemistry, vol. 294, no. 47, pp. 17818–17836, 2019, doi: 10.1074/jbc.ra119.009521.

BibTeX

@article{omi2019activin,
  title     = {{Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway}},
  author    = {Omi, Maiko and Kaartinen, Vesa and Mishina, Yuji M.},
  journal   = {Journal of Biological Chemistry},
  year      = {2019},
  volume    = {294},
  number    = {47},
  pages     = {17818--17836},
  doi       = {10.1074/jbc.ra119.009521},
  url       = {https://doi.org/10.1074/jbc.ra119.009521}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202066
202177
202244
202366
20241111
202544
202677

Its field-weighted citation impact is 1.18: it has been cited 1.18 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases

  • ACVR1
  • BMP signaling
  • BMP-7
  • osteoclastogenesis
  • RANKL
  • Smad1/5/9 signaling
  • NFATc1
  • osteoclast fusion

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Omi, M., Kaartinen, V., & Mishina, Y. M. (2019). Activin A receptor type 1–mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway. Journal of Biological Chemistry, 294(47), 17818–17836. https://doi.org/10.1074/jbc.ra119.009521

How many times has this paper been cited?

46 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Biological Chemistry: sign in and open the PDF from this page.

Who wrote this paper?

Maiko Omi, Vesa Kaartinen, Yuji M. Mishina.

What is the DOI of this paper?

10.1074/jbc.ra119.009521, permanently at https://doi.org/10.1074/jbc.ra119.009521. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.